Pharmacists in Havelock, North Carolina


13 Pharmacists found in Havelock
female pharmacist

Anna Brown


Pharmacist
101 W Main St, Havelock, NC 28532
252-447-6303    

female pharmacist

Ashli Miller Heustess, PHARMD


Pharmacist
566 Us Highway 70 W, Havelock, NC 28532
252-444-0885    

male pharmacist

Dr. Atsnaf Melaku Gebremariam, PHARMD


Pharmacist
566 Us Highway 70 W, Havelock, NC 28532
252-444-2055    



female pharmacist

Celeste Malishewsky


Pharmacist
1204 E Main St, Havelock, NC 28532
252-444-0910     252-444-0721

female pharmacist

Genevieve Nkiruka Anakwe Charles, PHARMD


Pharmacist
4389 Beaufort Road, Havelock, NC 28532
252-466-0921    

male pharmacist

John Eric Demoret, PHARMD


Pharmacist
101 W Main St, Havelock, NC 28532
252-447-6303    

male pharmacist

Joseph T Covington, PHARMD


Pharmacist
566 Us Highway 70 W, Havelock, NC 28532
336-339-3413    

female pharmacist

Mary Anna Tayloe


Pharmacist
510 Us Highway 70 W, Havelock, NC 28532
252-447-8033     252-447-0101

female pharmacist

Meredith Brooke Reagan


Pharmacist
103 Catawba Rd, Havelock, NC 28532
252-447-8033    

male pharmacist

Dr. Steven Gillenwater, PHARMD


Pharmacist
103 Catawba Rd, Havelock, NC 28532
252-447-8033    

female pharmacist

Subodha Lingayat


Pharmacist
101 W Main St, Havelock, NC 28532
252-447-6303     252-447-3710

female pharmacist

Susan Williams Robertson


Pharmacist
566 Us Highway 70 W, Havelock, NC 28532
252-444-0885     252-444-8736

female pharmacist

Tara-dawm R Tootle, PHARMD


Pharmacist
1204 E Mail St, Havelock, NC 28532
252-444-1061    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.